BIOSQUAL Overview
- Founded
-
2015
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
BIOSQUAL General Information
Description
Developer of analogues of squalamine based in France. The company develops a series of analogues of squalamine and pharmaceutical formulations for clinical use.
Contact Information
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
- 10, rue Clapier
- 13001 Marseille
- France
BIOSQUAL Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 17-Feb-2022 | 00000 | Completed | Out of Business | ||
| 2. Angel (individual) | 05-Nov-2018 | 00000 | 00000 | 00000 | Completed | Startup |
| 1. Accelerator/Incubator | Completed | Startup |
BIOSQUAL Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | 000 | 000.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 000 |
BIOSQUAL Patents
BIOSQUAL Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| FR-3092490-A1 | Squalamine-like aminosteroid compound for use in the treatment and / or prevention of dermatophytosis | Inactive | 08-Feb-2019 | 0000000000 | 0 |
| FR-3092492-A1 | Cosmetic use of an aminosteroid compound analogous to squalamine to reduce or prevent bad skin odor | Inactive | 08-Feb-2019 | 00000000 | 0 |